Avenue Therapeutics, Inc.
ATXI·05360L205·US·Common Stock·Healthcare - Biotechnology
ATXI (Avenue Therapeutics, Inc.) is held by 0 institutional investors as of Q1 2025. Net institutional sentiment: Bearish.
0
Holders
$0
Total Value
0% (3)
Consensus
0 buying - 3 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Sep 10, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for ATXI.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $28 | 0.0% | -84.02% | 0 | |
Exited | 0(-100.0%) | $1,000 | 0.0% | -96.03% | 0 | |
Exited | 0(-100.0%) | $15,840 | 0.0% | -87.43% | 0 |
ATXIAvenue Therapeutics, Inc.Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO403 holders · $856.6B
UNHUNITEDHEALTH GROUP INC403 holders · $286.8B
TMOTHERMO FISHER SCIENTIFIC INC388 holders · $148B
JNJJOHNSON & JOHNSON385 holders · $405.5B
DHRDANAHER CORP DEL384 holders · $95B
ISRGINTUITIVE SURGICAL INC381 holders · $105.8B
MRKMERCK & CO INC378 holders · $226B
BSXBOSTON SCIENTIFIC CORP375 holders · $51.2B
ABBVABBVIE INC373 holders · $296.3B
ABTABBOTT LABORATORIES371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer